glp 1 drugs and cancer GLP-1 may reduce the risk of progressing, study suggests New study examines GLP-1 drugs
Description
If tirzepatide stopped working Distinguish between true pharmacological tolerance and a weight loss plateau caused by metabolic adaptation

These injections are designed to mimic the actions of the naturally occurring GLP-1 hormone, which plays a crucial role in regulating insulin secretion, glucose homeostasis, and appetite

The most frequent adverse effects are gastrointestinal and dose-related: Nausea, vomiting, diarrhoea, constipation, and abdominal discomfort - Typically worst during dose escalation and often resolve or attenuate with continued treatment and slower titration

Also, LIXI is well tolerated, and nausea and vomiting are the most commonly reported adverse events (66, 67)
